Reduced number and area of tumors. Decreased histoscore tumor burden and the expression of proliferation marker PCNA. Reduced key mediators that link the inflammation with colorectal cancer such as: inflammatory mediator TNF-α, and oncogenic transcription factors STAT3 and NFκB. This evidence concerns the gene NFKB1 and colorectal cancer.